Protein S100 as Prognostic Marker for Gastrointestinal Stromal Tumors: A Clinicopathological Risk Factor Analysis

REFERENCES

• Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol. 1999; 10: 1213–1220
   Google Scholar
• Miettinen M, Lasota J. Gastrointestinal stromal tumors—Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001; 1: 1–12
   Google Scholar
• Sakurai S, Fukasawa T, Chong J M, Tanaka A, Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol. 1999; 1: 23–28
   Google Scholar
• Graadt van Roggen J F, van Velthuysen M L, Hogendoorn P C. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol. 2001; 2: 96–102
   Google Scholar
• Ng E H, Pollock R E, Munsell M F, Atkinson E N, Romsdahl M M. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg. 1992; 1: 68–77
   Google Scholar
• Ozguc H, Yilmazlar T, Yerci O, Soylu R, Tumay V, Filiz G, Zorluoglu A. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg. 2005; 3: 418–429
   Google Scholar
• Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: Analysis of results in 140 surgically resected patients. Gastric Cancer. 2003; 1: 39–48
   Google Scholar
• Tazawa K, Tsukada K, Makuuchi H, Tsutsumi Y. An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors. Pathol Int. 1999; 9: 786–798
   Google Scholar
• Bucher P, Taylor S, Villiger P, Morel P, Brundler M A. Are there any prognostic factors for small intestinal stromal tumors?. Am J Surg. 2004; 6: 761–766
   Google Scholar
• Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol. 2002; 6: 669–676
   Google Scholar
• Fletcher C D, Berman J J, Corless C, Gorstein F, Lasota J, Longley B J, Miettinen M, O'Leary T J, Remotti H, Rubin B P, Shmookler B, Sobin L H, Weiss S W. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002; 5: 459–465
   Google Scholar
• Molina R, Navarro J, Filella X, Castel T, Ballesta A M. S-100 protein serum levels in patients with benign and malignant diseases: False-positive results related to liver and renal function. Tumour Biol. 2002; 1: 39–44
   Google Scholar
• Harpio R, Einarsson R. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin Biochem. 2004; 7: 512–518
   Google Scholar
• Mohammed M Q, Abraha H D, Sherwood R A, MacRae K, Retsas S. Serum S100beta protein as a marker of disease activity in patients with malignant melanoma. Med Oncol. 2001; 2: 109–120
   Google Scholar
• Smit L H, Korse C M, Hart A A, Bonfrer J M, Haanen J B, Kerst J M, Nieweg O E, de Gast G C. Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients. Eur J Cancer. 2005; 3: 386–392
   Google Scholar
• Zimmer D B. Examination of the calcium-modulated protein S100 alpha and its target proteins in adult and developing skeletal muscle. Cell Motil Cytoskeleton. 1991; 4: 325–337
   Google Scholar
• Donato R. Perspectives in S-100 protein biology. Review article. Cell Calcium. 1991; 10: 713–726
   Google Scholar
• Heizmann C W, Cox J A. New perspectives on S100 proteins: A multi-functional Ca(2+)-, Zn(2+)-and Cu(2+)-binding protein family. Biometals. 1998; 4: 383–397
   Google Scholar
• Miettinen M, Lasota J, Sobin L H. Gastrointestinal stromal tumors of the stomach in children and young adults: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol. 2005; 10: 1373–1381
   Google Scholar
• Griffin W S. Inflammation and neurodegenerative diseases. Am J Clin Nutr. 2006; 2: 470S–474S
   Google Scholar
• Kitamura Y, Hirota S, Nishida T. Gastrointestinal stromal tumors (GIST): A model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci. 2003; 4: 315–320
   Google Scholar
• Bassotti G, Battaglia E, Bellone G, Dughera L, Fisogni S, Zambelli C, Morelli A, Mioli P, Emanuelli G, Villanacci V. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol. 2005; 9: 973–977
   Google Scholar
• Popescu L M, Ciontea S M, Cretoiu D, Hinescu M E, Radu E, Ionescu N, Ceausu M, Gherghiceanu M, Braga R I, Vasilescu F, Zagrean L, Ardeleanu C. Novel type of interstitial cell (Cajal-like) in human fallopian tube. J Cell Mol Med. 2005; 2: 479–523
   Google Scholar
• Rudolph P, Chiaravalli A M, Pauser U, Oschlies I, Hillemanns M, Gobbo M, Marichal M, Eusebi V, Hofler H, Capella C, Kloppel G. Gastrointestinal mesenchymal tumors—Immunophenotypic classification and survival analysis. Virchows Arch. 2002; 3: 238–248
   Google Scholar
• Lerma E, Oliva E, Tugues D, Prat J. Stromal tumours of the gastrointestinal tract: A clinicopathological and ploidy analysis of 33 cases. Virchows Arch. 1994; 1: 19–24
   Google Scholar
• Rudolph P, Gloeckner K, Parwaresch R, Harms D, Schmidt D. Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study. Hum Pathol. 1998; 8: 791–800
   Google Scholar
• Emory T S, Sobin L H, Lukes L, Lee D H, O'Leary T J. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site. Am J Surg Pathol. 1999; 1: 82–87
   Google Scholar
• Orosz Z, Tornoczky T, Sapi Z. Gastrointestinal stromal tumors: A clinicopathologic and immunohistochemical study of 136 cases. Pathol Oncol Res. 2005; 1: 11–21
   Google Scholar
• de Schipper J P, Liem R S, van den Ingh H F, van der Harst E. Revision of gastrointestinal mesenchymal tumours with CD117. Eur J Surg Oncol. 2004; 9: 959–962
   Google Scholar
• Miettinen M, Kopczynski J, Makhlouf H R, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin L H, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003; 5: 625–641
   Google Scholar
• Abdulkader I, Cameselle-Teijeiro J, Gude F, Fraga M, Varela-Duran J, Barreiro F, Forteza J. Predictors of malignant behaviour in gastrointestinal stromal tumours: A clinicopathological study of 34 cases. Eur J Surg. 2002; 5: 288–296
   Google Scholar
• Hou Y, Wang J, Zhu X, Du X, Sun M, Zheng A. A clinicopathologic and immunohistochemical study on 76 cases of gastrointestinal stromal tumors. Zhonghua Bing Li Xue Za Zhi. 2002; 1: 20–25
   Google Scholar
• Morey A L, Wanigesekera G D, Hawkins N J, Ward R L. C-kit mutations in gastrointestinal stromal tumours. Pathology. 2002; 4: 315–319
   Google Scholar
• Singer S, Rubin B P, Lux M L, Chen C J, Demetri G D, Fletcher C D, Fletcher J A. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol. 2002; 18: 3898–3905
   Google Scholar